Lung Disease News and Research

RSS

Remdesivir prevents COVID-19 progression to severe pneumonia, animal study shows

A team of scientists at the National Institute of Allergy and Infectious Diseases, which is part of the U.S. National Institutes of Health, has tested the efficacy of remdesivir, a nucleotide analog prodrug with a broad antiviral activity, as a COVID-19 treatment.

20 Apr 2020

Regular exercise may reduce risk of deadly complication in patients with COVID-19

Regular exercise may reduce the risk of acute respiratory distress syndrome, a major cause of death in patients with the COVID-19 virus, a top exercise researcher reports.

15 Apr 2020

ECMO physicians outline guidance to treat critically ill COVID-19 patients

Rapidly escalating numbers of COVID-19 patients suffering from respiratory failure threaten to overwhelm hospital capacity and force healthcare providers into making challenging decisions about the care they provide.

15 Apr 2020

Novel coronavirus attacks and destroys T cells, just like HIV

The immune system has many components that work together in protecting the body from foreign invaders. One of the most important types of immune cells is T lymphocytes or T cells, a type of white blood cell that acts as the core of adaptive immunity, the system that modifies the immune response to specific pathogens.

13 Apr 2020

American Lung Association launches a $25M initiative to end COVID-19

As the nation’s leading voluntary lung health organization, the American Lung Association is launching a $25M initiative to end COVID-19 and defend against future respiratory virus pandemics.

10 Apr 2020

‘Entry Point’ enzyme for COVID-19 higher in COPD patients and smokers

News-Medical speaks to Professor Don Sin on his research into COVID-19 and its effect on smokers and people suffering from COPD.

9 Apr 2020

Early smoking causes greater addiction

A new study shows that people who start smoking younger are more likely to continue to smoke daily as adults and find it much harder to quit. The study, published in the Journal of the American Heart Association in April 2020, is remarkable for having the most prolonged follow-up period of any similar study.

8 Apr 2020

Spanish study shows infections in children occur early in COVID-19 epidemics

With the spread of COVID-19, scientists are finding out more about the disease. One major aspect that is being studied is how the virus affects children. A new report from Spain, published in the journal JAMA Pediatrics in April 2020, shows that pediatric populations are infected early in the epidemic and that about 10% of those with symptoms suggestive of infection test positive. Severe infection can also occur among children, requiring hospitalization and intensive care.

8 Apr 2020

Smokers need to quit during coronavirus pandemic

Smoking tobacco may aggravate the effects of coronavirus disease (COVID-19). Health experts are urging smokers to quit and cigarette companies to stop producing tobacco products to help alleviate the risks of COVID-19. A new study from China highlights the risk of smoking during the coronavirus pandemic.

7 Apr 2020

Healthy lifestyle, greater disease-free life expectancy

For years, doctors have been advocating a healthy diet, more regular exercise, stress relief, and weight control. However, no study has examined a combination of all these factors with the number of years that one can live free of major chronic disease. This could help communicate the benefits of a healthy lifestyle more convincingly than the commonly reported relative risk of disease with each of these risk factors.

6 Apr 2020

DsbA-L gene may play a role in protecting respiratory function of the elderly

The lungs are constantly exposed to the external environment and maintain homeostasis by adapting to stress and tissue damage.

6 Apr 2020

Long-standing racial and income disparities seen creeping into COVID-19 care

The new coronavirus doesn’t discriminate. But physicians in public health and on the front lines said they already can see the emergence of familiar patterns of racial and economic bias in the response to the pandemic.

6 Apr 2020

Estimating the case fatality ratio for COVID-19

The Severe Acute Respiratory Syndrome Corona Virus (SARS-CoV-2) that causes COVID-19 disease has affected 932,605 individuals and has taken 46,809 lives worldwide. Now, researchers have published a review on the likelihood of survival after SARS-CoV-2 infection. The study titled, “Likelihood of survival of coronavirus disease 2019” is published in the latest issue of The Lancet Infectious Diseases.

1 Apr 2020

Antihypertensive drugs may protect against COVID-19 in heart patients

Common drugs used in high blood pressure, heart failure, and diabetic patients with kidney damage, including angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs), could be protective in patients with COVID-19.

31 Mar 2020

Location of broken bone in older people can have major impact on long-term health outcomes

In older individuals, the location of a broken bone can have significant impacts on long-term health outcomes, according to research accepted for presentation at ENDO 2020, the Endocrine Society's annual meeting, and publication in a special supplemental section of the Journal of the Endocrine Society.

31 Mar 2020

Three Australian experts explain the course of COVID-19

Researchers have been studying the ongoing pandemic of COVID-19 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) closely since its beginning in December 2019. To date, the virus has infected over 850,000 individuals across the globe and killed over 41,000.

31 Mar 2020

Sheltered at home, families broach end-of-life planning

Long before she contracted COVID-19 at a Kirkland, Washington, nursing home, Barbara Dreyfuss made sure to document the wishes that would govern how she died.

31 Mar 2020

Understanding the novel coronavirus genome

The novel coronavirus emerged in December 2019 in Wuhan City, Hubei Province, in China, and since then, it has rapidly spread to over 170 countries across the globe. Our knowledge of the virus, now officially named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is still in the early stages. However, scientists around the world are racing to better understand the virus, in the hope of shedding light on potential vaccines and therapies.

31 Mar 2020

New virtual tool to help the world diagnose COVID-19 in the lungs

A new virtual tool helps overstressed and overworked doctors sharpen their skills at making a timely diagnosis of COVID-19 pneumonia based on the characteristic lung signs on computerized tomography (CT) of the chest.

31 Mar 2020

How to boost your immune system to fight coronavirus

As the world struggles with the coronavirus pandemic, more and more people are trying to protect themselves against the virus by all means possible. There are currently no vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), so boosting the immune system by way of diet, regular exercise, and sleep are sensible measures.

31 Mar 2020